Poly(ADP-ribose)polymerase inhibitors-associated myeloid neoplasms: a retrospective study from the French Network of Pharmacovigilance centres.
| Authors | Pierre-Marie Morice, Alexis Genthon, Thomas Boyer, Kevin Bihan, Julien Mahé, Anthony Sourisseau, Hélène Peyrouzet, Ghada Miremont, Marion Lepelley, Laetitia Stefani, Louise Gaboriau, Fanny Rocher, Danièle Aquaronne, Christine Le Beller, Marion Allouchery, Brahim Azzouz, Nathalie Massy, Martine Alt-Tebacher, Célestine Simand, Raoul Herbrecht, Basile Chrétien, Charles Dolladille, Sylvain Chantepie, Joachim Alexandre |
| Journal | British journal of haematology
(Br J Haematol)
Vol. 196
Issue 3
Pg. 787-793
(02 2022)
ISSN: 1365-2141 [Electronic] England |
| PMID | 34611896
(Publication Type: Letter, Multicenter Study)
|
| Chemical References |
- Poly(ADP-ribose) Polymerase Inhibitors
|
| Topics |
- Cross-Sectional Studies
- Female
- France
(epidemiology)
- Humans
- Male
- Myeloproliferative Disorders
(diagnosis, epidemiology, etiology)
- Neoplasms, Second Primary
(diagnosis, epidemiology, etiology)
- Pharmacovigilance
- Poly(ADP-ribose) Polymerase Inhibitors
(adverse effects, therapeutic use)
- Retrospective Studies
|
|
Join CureHunter, for free Research Interface BASIC access!
Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease.
Find out why thousands of doctors, pharma researchers and patient activists
around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!
|
